‘Prepare For COVID-19 Vaccine Launch on November 1st’
According to media reporting, ‘the U.S. Department of Health and the Centers for Disease Control and Prevention (CDC) are rapidly making preparations to implement a large-scale distribution of COVID-19 vaccines in the Fall of 2020.’
According to a letter obtained by McClatchy, the CDC’s Director Robert Redfield told the governors of the US states on August 27, 2020: "This vaccine distribution is expected to be a public health effort of significant scale, potentially involving hundreds of millions of vaccine doses to be distributed across the U.S."
The CDC said they will be using McKesson Corporation to distribute the vaccines to state and local agencies, medical facilities, and vaccine providers. To accomplish these services, McKesson has to acquire licenses and permits.
The CDC Directors’ letter made clear that any potentially waived requirements "will not compromise the safety or integrity of the products being distributed."
"These permits are needed to allow McKesson to distribute the vaccine into or from your state," the letter continued, noting these distribution facilities from becoming fully operational by Nov. 1, 2020.”
As of September 2, 2020, an updated listing of SARS-CoV-2 coronavirus vaccine candidates is published at CoronavirusToday.
Additionally, McClatchy reported that Dr. Nancy Messonnier, a CDC official warned state public health departments to draft plans for the distribution of COVID-19 vaccines – and requested states submit proposals by October 1st.
And, the CDC's vaccine advisory committee released its draft plan for vaccine distribution on August 26, 2020.
Previously, on August 14, 2020, McKesson announced ‘it was expanding its existing partnership with the CDC to support the U.S. government’s Operation Warp Speed team as a centralized distributor of the future COVID-19 vaccines and ancillary supplies needed to administer vaccinations.’
And, ‘these vaccines and related supplies will be delivered to point-of-care sites across the country at the U.S. government’s direction.’
McKesson stated ‘it will utilize its expertise and capabilities, along with other industry partners, to support the CDC’s efforts to vaccinate everyone in the USA who wants to receive a COVID-19 vaccine.’
The CDC and McKesson collaborated similarly in response to the H1N1, Swine Flu pandemic.
The CDC has an existing contract with McKesson to support distribution as part of the CDC’s Vaccines for Children Program.
Beyond programs with the CDC, McKesson is the largest seasonal flu vaccine distributor in the USA and distributes up to 150 million doses of all vaccines annually to public health clinics, hospitals, physician offices, nursing homes, pharmacies, and other care facilities.
Separately, the U.S. FDA announced on August 27, 2020, that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on October 22nd, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19 disease.
PrecisionVaccinations publishes research-based news regarding the COVID-19 pandemic.